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ABSTRACT
West Virginia leads the nation in substance abuse deaths per capita. This epidemic has given rise to a novel 
population of high-risk, obstetric patients with opiate abuse. Appropriate education, counseling, and imple-
mentation of contraception are of extreme importance among this population, due to the risks of unintended 
pregnancy. This study was a retrospective chart review to determine compliance and uptake of contraceptive 
methods by patients in a maternal buprenorphine maintenance program prior to and following implementa-
tion of standardized contraception education and Medicaid coverage of immediate postpartum long-acting 
reversible contraceptives (LARC). Rates of planned contraception and rates of actual method initiation were 
compared between two groups representing two distinct time periods before and after the intervention. 
Rates of highly effective contraception options were noted to significantly increase following dedicated 
education and Medicaid coverage (p = 0.04). Patients receiving no contraception at all significantly decreased 
following these interventions (p = 0.003). Patients desiring surgical sterilization continued to encounter barri-
ers to care as the rate of actual sterilization to desired sterilization remained low.
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For two consecutive years in 2017 and 2018, West 
Virginia had the highest number of overdose deaths 
per capita in the United States at 57.8 and 51.5 per 
100,000, respectively.1 Among the sizable opioid 
abusing population of West Virginia, the obstetric 
population has emerged as a high-risk cohort neces-
sitating specialized care during the antepartum and 
postpartum periods. An important aspect of their 
obstetric care is postpartum contraception manage-
ment. Long-acting reversible contraceptives (LARC), 
such as intrauterine devices (IUDs) and implants, are 
the most effective forms of reversible contraception 
and do not require user effort to be effective.2 Given 
that the rate of unintended pregnancy is estimated 
at 86% among opioid-dependent women, the use of 
effective contraception for this patient population is 
paramount.3 LARC methods are the least expensive 
forms of reversible contraception over five years,4 ex-
hibit normal returns of fertility after discontinuation, 
have a low rate of complications, and have high rates 
of patient satisfaction.5 LARC methods would benefit 
these high-risk pregnant women with opiate abuse. 
This population faces several unique barriers to 
appropriate contraception management including 
compliance, knowledge deficits, and access to care. 
It has been previously established that this patient 
population has very poor compliance to postpartum 
visits, a time when most contraceptive counseling 
and implementation occur.6 Additionally, state law 
currently mandates that written consent must be 
obtained 30 days in advance of any routine delivery 
or 72 hours in advance of a preterm delivery for a 
sterilization procedure to be covered by Medicaid7; 
this stipulation can prevent women with undesired 
fertility from pursuing sterilization due to concerns 
for out-of-pocket cost. According to the Contracep-
tive CHOICE project, in the absence of barriers such as 
knowledge and cost, the rate of initiation of LARC was 
higher than other contraceptive methods. Accessible, 
affordable, easy-to-use contraception, such as LARC, 
should be a major focus when counseling these high-
risk patients.8
The Maternal Addiction and Recovery Center (MARC) 
program at our institution provides specialty care 
for pregnant women with substance abuse. In a past 
study looking at a cohort of women from 2010-2014, 
planned and actual contraception were evaluated, 
along with compliance with a postpartum visit. This 
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study demonstrated poor LARC uptake among 
women with substance abuse, poor compliance with 
pre-pregnancy desired contraception choices, an in-
creased rate of changing to lower efficacy contracep-
tion options, and poor compliance with postpartum 
visits.9 Since this study, a standardized contraception 
counseling intervention was implemented with-
in the MARC program. This intervention provided 
education to MARC patients about all birth control 
methods during their antenatal care. Additionally, in 
2016, West Virginia Medicaid implemented coverage 
for immediate postpartum (IPP) LARC placement. IPP 
LARCs are done immediately after delivery during the 
inpatient stay. This practice is thought to reduce bar-
riers and improve compliance with LARC methods. 
The purpose of this study was to determine if con-
traception education provision and IPP LARC access 
improved contraception usage among pregnant 
women with opiate abuse. Furthermore, it was the 
aim of this study to review all contraception choices 
and successful initiation of those choices among this 
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high-risk obstetric population.
METHODS
This study was a retrospective chart review including 
patients enrolled in the MARC program. We defined 
the population prior to implementation of any bar-
rier-to-care interventions as those patients actively 
enrolled into the MARC program for their obstetric 
care from 1/2010-12/2014 (cohort 1), and the popu-
lation after implementation of interventions as those 
patients actively enrolled into the MARC program for 
their obstetric care from 1/2016-12/2018 (cohort 2). 
The first barrier-to-care intervention was the imple-
mentation of a dedicated contraception education 
curriculum. The MARC program has a rotating list of 
speakers to discuss various topics with the partic-
ipants. Approximately every 12 weeks, an OBGYN 
physician conducted an hour-long formal education-
al session with MARC participants. This session edu-
cated MARC patients on all forms of contraception 
including LARC methods and sterilization methods 
such as bilateral tubal ligation and vasectomy. The 
risks, benefits, bleeding patterns, and procedures of 
each method were reviewed with adequate time for 
questions and discussion. The second intervention 
was new legislation providing Medicaid coverage of 
immediate postpartum LARC methods. 
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Data collection concluded prior to 2015 to allow for 
a full year of follow-up in order to assess the preva-
lence of short-interval repeat pregnancy. Short-in-
terval repeat pregnancy was defined as pregnancy 
within a year of delivery. Data were not collected on 
those patients who were pregnant in 2015 to avoid 
overlapping the allotted 1 year follow-up period 
with the implementation of our interventions in 
2016. Prenatal charts were reviewed for planned 
contraception, defined as the contraceptive method 
documented antenatally that the patient wanted 
following delivery. Charts were also reviewed for 
actual contraception, defined as the contraceptive 
method the patient actually received following deliv-
ery. Patients’ postpartum notes were used to assess 
postpartum visit compliance as well as compliance 
or successful implementation of contraception 
within six weeks of delivery. Short-interval repeat 
Figure 1: Patients desiring bilateral tubal ligation for contraception vs. patients receiving 
BTL. Cohort 1 – 13 (56.5%) vs. Cohort 2 – 43 (55.8%) (p= .95)
Figure 2: Patients desiring LARC for contraception vs. patients receiving LARC. Cohort 1 
– 6 (16.7%) vs. Cohort 2 – 27 (60%) (p=.04)
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pregnancies were evaluated based on return office 
visits for a new pregnancy within one year of the 
antecedent pregnancy. Demographic data were col-
lected from the prenatal record including age, race, 
gravidity, parity, mode of delivery, smoking status, 
and history of sexually transmitted diseases. Contra-
ception options were placed into tiers according to 
efficacy: Tier 1 – LARC and sterilization methods; Tier 
2 – hormonal contraceptives including birth control 
pills, ring, and depot medroxyprogesterone; and Tier 
3 – barrier methods including condoms/diaphragms, 
undecided, or no contraception. Contraceptive use, 
follow-up, rapid repeat pregnancy rates, and chang-
es in contraceptive efficacy (from what was planned 
to what was actually given) were compared between 
groups. Continuous variables were analyzed using a 
t-test, and categorical variables were analyzed using 
a chi-square or Fisher’s exact test.
RESULTS
There were 61 patients included in cohort 1 and 173 
patients included in cohort 2. Upon comparison of 
the two groups, the only statistically different demo-
graphic value between them was a difference in the 
mean age (Table 1; cohort 1 – 26.7 years, SD 5.1; co-
hort 2 – 28.7 years, SD 4.5; p = 0.003). Of note, there 
were 19 patients in cohort 1 who had no documen-
tation of any insurance type or self-pay status who 
were not included in that portion of the demograph-
ic data. Rates of postpartum visit compliance within 
6 weeks were noted to be 32 (52.5%) for cohort 1 and 
87 (50.3%) for cohort 2 and did not differ between 
the cohorts (p = 0.77) (Table 2). Rates of short-inter-
val repeat pregnancy also did not differ significantly 
between the cohorts: 4 (6.6%) in cohort 1 and 10 
(5.8%) in cohort 2 (p = 0.83) (Table 2). The rate of 
“undecided/none” as a planned method of contra-
ception as documented antepartum significantly 
decreased from 23 (37.7%) in cohort 1 to 33 (19.1%) 
in cohort 2 (p = 0.003) (Table 3). The “actual con-
traception initiated” rate for progesterone implant 
significantly increased from 0 (0%) in cohort 1 to 19 
(11%) in cohort 2 (p = 0.007) (Table 4). The overall 
percentage receiving Tier 1 contraception methods 
increased significantly from 18 (29.5%) to 83 (48.0%) 
(p = 0.012). Of those patients desiring bilateral tubal 
ligation for contraception, 13 of the 23 patients in 
cohort 1 (56.5%) and 43 of the 77 in cohort 2 (55.8%) 
actually received a sterilization procedure (p = .95) 
(Figure 1). Of the 6 patients who desired LARC ante-
partum, only one patient received LARC in cohort 1 
(16.7%) as compared to 27 of the 45 (60%) in cohort 
2 (p = 0.04) (Figure 2). 
DISCUSSION
At the start of this study, WV Medicaid initiated 
reimbursement for immediate postpartum (IPP) 
LARC provision, effectively ameliorating two of the 
proposed barriers to care facing substance abuse pa-
tients: poor compliance with postpartum follow-up 
and concern for cost. Prior to 2016, patients desiring 
LARC were required to attend postpartum visits to 
obtain a contraceptive implant or IUD. Nearly half of 
the MARC population (45.9%), regardless of planned 
contraception method, received no contraception 
postpartum in cohort 1. With the implementation of 
rigorous in-office resident-physician counseling and 
availability of IPP options, that number decreased to 
19.1% in cohort 2. After making IPP LARC available, 
significantly more patients from cohort 2 chose LARC 
methods antepartum (45%) and actually imple-
mented LARC methods postpartum (n=27, 60% of 
expected). This finding is in contrast to other studies 
demonstrating low use of LARCs among opioid-ad-
dicted patients from 5-13%.10,11 Despite improve-
ments in contraception counseling and implemen-
tation of planned contraception, significant loss to 
follow-up among MARC patients persisted between 
cohorts (52.5% vs. 50.3% [p = 0.77]). This persistent 
non-compliance with postpartum visits emphasizes 
the importance of antepartum contraception coun-
seling, provision of LARC options prior to leaving 
the hospital, and ensuring those patients with 
undesired fertility actually receive their sterilization 
procedures. The vast majority of patients included in 
this trial were Medicaid recipients (92.5%) and were 
therefore eligible for IPP LARC options. Regardless of 
their antepartum contraception choices, adequate 
counseling on the safety, efficacy, ease of use, and 
cost coverage of LARC options should be provided to 
these patients. 
In our study, only 55.8% of MARC patients in cohort 
2 received a bilateral tubal ligation when desired; 
this is consistent with the rate from cohort 1 (56.5%). 
There are multiple proposed reasons for the low 
rate of surgical sterilization. West Virginia Medicaid 
requires patients to be over 21 years old, to be med-
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ically competent, and to have signed a state bilateral 
tubal ligation consent form 30 days in advance but 
not more than 180 days in advance of delivery. 
There is an emergent delivery/abdominal surgery 
clause, however, stating that the time from consent 
to the time of delivery/surgery must be 72 hours. 
These stringent additional stipulations may deter pa-
tients with undesired fertility from pursuing surgical 
sterilization. Additionally, operating room availability, 
surgeon availability, and anesthesia availability often 
preclude immediate post-delivery tubal ligations 
which may further contribute to the low rate of com-
pletion of desired sterilization procedures.
As a retrospective chart review, the data are limited 
by accurate medical records, in this instance resident 
clinic antepartum and postpartum documenta-
tion. Further limitations included loss-to-follow-up. 
Among patients that did not keep postpartum fol-
low-up, it is impossible to determine if they pursued 
any form of contraception with another provider or 
went on to have a rapid-repeat pregnancy. A final 
confounding factor was the introduction and imple-
mentation of multiple interventions simultaneously. 
It is difficult to distinguish which intervention had a 
greater impact upon patient contraception choice: 
increased counseling or greater ease of access to 
care. 
We have documented an increase in postnatal LARC 
uptake and reductions in no-contraception as a 
planned method of contraception following the 
introduction of structured prenatal contraception 
education and concurrent Medicaid coverage for 
immediate postnatal effective contraception. As 
numbers and follow-up increase, we speculate that 
these findings will translate into a reduced number 
of unintended pregnancies in this vulnerable pop-
ulation. Continued efforts must be made to appro-
priately educate and counsel the high-risk obstetric 
population with substance abuse in West Virginia 
regarding contraception options and availability. It is 
the responsibility of obstetric providers to continue 
to educate patients on the safety, efficacy, and ease 
of use related to LARC methods as these methods 
become more easily available immediately postpar-
tum. It is also paramount to continue identifying and 
rectifying barriers keeping high-risk patients from 
the care they deserve.
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